Rehm BHA - Search Results

1

A phase I/II randomized, controlled, clinical trial for assessment of the efficacy and safety of β-D-mannuronic acid in rheumatoid arthritis patients.

Ahmadi H, Jamshidi AR, Gharibdoost F, Mahmoudi M, Rastkari N, Mostafaei S, Fattahi MJ, Vojdanian M, Cuzzocrea S, Rehm BHA, Matsuo H, Hosseini M, Aghazadeh Z, Mortazavi-Jahromi SS, Mirshafiey A. Ahmadi H, et al. Among authors: rehm bha. Inflammopharmacology. 2018 Jun;26(3):737-745. doi: 10.1007/s10787-018-0475-z. Epub 2018 Apr 25. Inflammopharmacology. 2018. PMID: 29696564 Clinical Trial.

2

Chemopreventive effect of M2000, a new anti-inflammatory agent.

Mirshafiey A, Khorramizadeh MR, Saadat F, Rehm BH. Mirshafiey A, et al. Med Sci Monit. 2004 Oct;10(10):PI105-9. Epub 2004 Sep 23. Med Sci Monit. 2004. PMID: 15448610

3

M-2000, as a new anti-inflammatory molecule in treatment of experimental nephrosis.

Mirshafiey A, Rehm BH, Sahmani AA, Naji A, Razavi A. Mirshafiey A, et al. Immunopharmacol Immunotoxicol. 2004;26(4):611-9. doi: 10.1081/iph-200042362. Immunopharmacol Immunotoxicol. 2004. PMID: 15658609

4

Sodium alginate as a novel therapeutic option in experimental colitis.

Mirshafiey A, Khodadadi A, Rehm BH, Khorramizadeh MR, Eslami MB, Razavi A, Saadat F. Mirshafiey A, et al. Scand J Immunol. 2005 Apr;61(4):316-21. doi: 10.1111/j.1365-3083.2005.01571.x. Scand J Immunol. 2005. PMID: 15853913 Free article.

5

Treatment of experimental arthritis with M2000, a novel designed non-steroidal anti-inflammatory drug.

Mirshafiey A, Cuzzocrea S, Rehm B, Mazzon E, Saadat F, Sotoude M. Mirshafiey A, et al. Scand J Immunol. 2005 May;61(5):435-41. doi: 10.1111/j.1365-3083.2005.01594.x. Scand J Immunol. 2005. PMID: 15882435 Free article.

6

Treatment of experimental immune complex glomerulonephritis by sodium alginate.

Mirshafiey A, Borzooy Z, Abhari RS, Razavi A, Tavangar M, Rehm BH. Mirshafiey A, et al. Vascul Pharmacol. 2005 Jun;43(1):30-5. doi: 10.1016/j.vph.2005.03.002. Vascul Pharmacol. 2005. PMID: 15893960

7

M2000: a revolution in pharmacology.

Mirshafiey A, Cuzzocrea S, Rehm BH, Matsuo H. Mirshafiey A, et al. Med Sci Monit. 2005 Aug;11(8):PI53-63. Epub 2005 Jul 25. Med Sci Monit. 2005. PMID: 16049391

8

Novel immunosuppressive therapy by M2000 in experimental multiple sclerosis.

Mirshafiey A, Matsuo H, Nakane S, Rehm BH, Koh CS, Miyoshi S. Mirshafiey A, et al. Immunopharmacol Immunotoxicol. 2005;27(2):255-65. doi: 10.1081/iph-200067751. Immunopharmacol Immunotoxicol. 2005. PMID: 16114509

9

Therapeutic approach by a novel designed anti-inflammatory drug, M2000, in experimental immune complex glomerulonephritis.

Mirshafiey A, Rehm B, Sotoude M, Razavi A, Abhari RS, Borzooy Z. Mirshafiey A, et al. Immunopharmacol Immunotoxicol. 2007;29(1):49-61. doi: 10.1080/08923970701282387. Immunopharmacol Immunotoxicol. 2007. PMID: 17464766

10

Production of M2000 (β-d-mannuronic acid) and its therapeutic effect on experimental nephritis.

Mirshafiey A, Rehm B, Abhari RS, Borzooy Z, Sotoude M, Razavi A. Mirshafiey A, et al. Environ Toxicol Pharmacol. 2007 Jul;24(1):60-6. doi: 10.1016/j.etap.2007.02.002. Epub 2007 Feb 16. Environ Toxicol Pharmacol. 2007. PMID: 21783790

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

190 results

Search Page